• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Movement Disorders
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

September 11, 2023

Study Examines Links Between Sleep, Testosterone, and Cortisol in Aging Men

Author(s):

Aislinn Antrim, Managing Editor

Hypercortisolemia during the late afternoon and early evening is harmful and believed to cause insulin resistance observed with advanced age.

New research published in PLoS One suggests that fixing testosterone-cortisol balance in men could mitigate the metabolic harm caused by sleep loss without requiring patients to sleep more. Sleep serves multiple vital functions, including neurobehavioral performance, improving immune function, and conserving energy expenditure through metabolic processes.

Image Credit: motortion - stock.adobe.com

Image Credit: motortion - stock.adobe.com

These benefits to metabolism, immunity, and cognition are crucial for healthy aging. However, the accumulation of sleep debt across the lifespan has negative impacts on all of these processes, which may be responsible for the development of diseases later in life.

Sleep debt accumulates throughout the lifespan as a result of insufficient sleep, misaligned sleep (such as with jetlag or night shiftwork), and disrupted sleep. Although individuals often try to “catch up” on sleep, this does not seem to completely reverse the adverse effects of sleep debt on multiple physiological processes, including psychomotor performance, metabolism, blood pressure regulation, and immune/adrenal response.

The accumulation of sleep debt is a widespread issue, with approximately 1 in 3 individuals getting insufficient sleep (<7 hours per night). Of those, an estimated 20% are shift workers with work schedules that misalign sleep. Additionally, 10% of men aged 30 to 49 years and 17% of men aged 50 to 70 years have at least moderate obstructive sleep apnea (OSA), which is a major cause of disrupted sleep. Insufficient, misaligned, and disrupted sleep is therefore likely to have major impacts on aging and the development of age-related diseases.

In their review, investigators primarily examined the effects of sleep disturbances on testosterone in the context of male gonadal aging. OSA and its interaction with testosterone is of particular importance because sleep architecture is disrupted and sleep duration is reduced.

Experts have long recommended that adults between the ages of 18 and 64 years require 7 to 9 hours of sleep per night, whereas adults over 65 years of age need 7 to 8 hours, including naps. Sleep needs decrease with age, but only up to age 60, after which sleep needs remain stable. Sleep architecture also changes with age, with rapid eye movement (REM) sleep decreasing and the proportion of stage 1 and 2 sleep increasing before age 60 and remaining stable afterward.

Like sleep, many longitudinal and cross-sectional studies of multiple populations have shown that testosterone declines with age in men. This decline is now recognized to be largely, although not exclusively, due to factors associated with aging, such as obesity and illness, rather than from aging itself.

A consistent relationship between sleep duration and testosterone has not been apparent in large cross-sectional studies of health community-dwelling older men. In their analysis of in-laboratory studies of sleep restriction on blood testosterone, only 1 study intensively sampled blood frequently enough to allow determination of pulse characteristics. Taken collectively, the studies showed that sleep restriction decreases testosterone, although importantly, most only assessed testosterone in the morning.

Only 1 study examined the effect of manipulating sleep in a cohort specifically including older men. In this study, 18 healthy older men and 17 healthy young men underwent total sleep deprivation and 8 hours of regular night sleep in random order. Although 24-hour, morning, and afternoon testosterone concentrations were all decreased by sleep restriction in both older and younger men, sleep restriction decreased the testosterone pulse frequency and pulsatile secretion only in older men.

Aging and sleep also intersect with cortisol. Multiple studies have shown that age is associated with higher late-afternoon and early-evening cortisol, and an advance in the timing of the cortisol rhythm. Notably, hypercortisolemia during the late afternoon and early evening is harmful and is believed to cause insulin resistance observed with advanced age, impaired physical performance, and neurocognitive deficits.

Some studies have suggested that sleep duration does not influence 24-hour or near 24-hour cortisol. However, recurrent self-reported short sleep duration is associated with higher late afternoon or bedtime salivary cortisol after 10 years of follow-up in a large occupational cohort of adults initially aged 35 to 55 years. These epidemiological data show that the effect of short sleep may be on a specific time of day in which higher cortisol levels result in metabolic harm, without any impact on 24-hour cortisol.

Finally, the investigators noted that cortisol and testosterone are, respectively, the major catabolic and anabolic signals in men. Changes in cortisol and testosterone signaling due to sleep restriction, specifically a reduction in testosterone and an increase in late-afternoon and early-evening cortisol, has long been suspected to be a mechanism by which sleep restriction induces insulin resistance. Randomized controlled trials have shown that testosterone treatment improves insulin sensitivity in men at risk for type 2 diabetes.

Based on all of the data analyzed, the researchers concluded that reciprocal changes in testosterone and cortisol as a result of sleep loss imbalance catabolic-anabolic signaling and is an important mechanism by which sleep loss induces insulin resistance.

By fixing the balance of testosterone and cortisol to prevent induced insulin resistance, the investigators said they provided the first proof-of-concept that the metabolic harm caused by sleep loss can potentially be mitigated by approaches that do not require more sleep. This could be particularly relevant for older men because the changes in testosterone-cortisol balance that occur in young men have been shown to also occur in older men.

Reference

Liu PY, Reddy RT. Sleep, testosterone and cortisol balance, and aging men. PLoS One. 2022;23(1323-1339). doi:10.1007/s11154-022-09755-4

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Related Content
Advertisement
Illustration of myocardial infarction
May 30th 2025

NLA 2025: Inclisiran With Standard Care Provides Rapid, Sustained Lowering of LDL-C in Patients With Recent Acute Coronary Syndrome

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Woman can't eat bread and grain products because of gluten intolerance. A young celiac woman suffers from abdominal pain after eating fresh bread - Image credit: weyo | stock.adobe.com
May 30th 2025

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy
May 30th 2025

NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy

Sander Kersten, PhD Alana Hippensteele, Lead Editor
Related Content
Advertisement
Illustration of myocardial infarction
May 30th 2025

NLA 2025: Inclisiran With Standard Care Provides Rapid, Sustained Lowering of LDL-C in Patients With Recent Acute Coronary Syndrome

Luke Halpern, Assistant Editor
Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings
May 28th 2025

Insights from a Pharmacy Times Peer Exchange: Toxicity Monitoring and Management in Real-World Settings

Alexandra Gerlach, Associate Editor
Woman can't eat bread and grain products because of gluten intolerance. A young celiac woman suffers from abdominal pain after eating fresh bread - Image credit: weyo | stock.adobe.com
May 30th 2025

FDA Grants Fast Track Designation to Drug Candidate for Celiac Disease

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Navigating Seasonal Allergies
May 28th 2025

Pharmacy Focus: Navigating Seasonal Allergies

Luke Halpern, Assistant Editor Derek Webb, PharmD
TKIs binding to target proteins | Image Credit: © Justlight - stock.adobe.com
May 30th 2025

Patient Reported Outcomes Show Improved Symptoms With Zongertinib for HER2-Mutated Non-Small Cell Lung Cancer

Alexandra Gerlach, Associate Editor
NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy
May 30th 2025

NLA 2025: The Complementary Roles of ANGPTL3 and ANGPTL4 in Lipid Regulation and Therapy

Sander Kersten, PhD Alana Hippensteele, Lead Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.